Rebalix
Xtrackers · sheet of 10 September 2026
Xtrackers · sheet of 10 September 2026ETF sheet · official issuer and register data
Xtrackers Msci Emerging Markets UCITS ETF 1c
IE00BTJRMP35 · IE00BTJRMP35 · USD · domicile Ireland
Equity · Emerging marketsSFDR art. 6 (inferred)
Index tracked: MSCI Total Return Net Emerging Markets Index (USD)
- TER
- 0.18%+ trans. 0.04%
- Fund size
- 12.4 bn EUR
- Tracking difference
- −0.03%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Accumulating
Launch 21 Jun 2017 · costs from the KID as of 2 Sept 2026 · 1,202 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to reflect the performance, before fees and expenses, of the MSCI Total Return Net Emerging Markets index (index) which is designed to reflect the performance of the shares of certain companies in global emerging market countries as determined by MSCI.
DESCRIPTION OF INDEX:
The companies comprising the index are large and medium sized companies based on the combined value of a company’s readily available shares as compared to other companies. A company’s weighting in…
Performance since series start (in euro) — base 100
21 Jun 2017 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +40.7% |
| 3 years | +76.9% |
| 5 years | +51.5% |
| 10 years | series too young |
| Since series start | +105.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 22.91% | 17.75% | 17.52% |
| Max drawdown | −13.52% | −15.72% | −33.94% |
| Sharpe | 1.44 | 1.11 | 0.40 |
| Sortino | 2.15 | 1.61 | 0.58 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BTJRMP35 · IE00BTJRMP351
RebalixIE00BTJRMP35 · IE00BTJRMP35 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +33.70% | +33.57% | +0.14% |
| 2024 | +7.52% | +7.50% | +0.02% |
| 2023 | +9.57% | +9.83% | −0.26% |
| 2022 | −20.22% | −20.09% | −0.13% |
| 2021 | −2.71% | −2.54% | −0.17% |
Holdings
Portfolio as declared by the issuer · 2 Sept 2026 · 1,202 securities · top-10 weight = 37.4%
| Top holdings | Weight |
|---|---|
| 15.2% | |
| 7.1% | |
| 5.5% | |
| 2.8% | |
| 1.9% | |
| 1.6% | |
| 0.9% | |
| 0.9% | |
| 0.8% | |
| 0.8% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
XMME · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
— · Nasdaq Stockholm
+ 19 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BTJRMP35
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BTJRMP35
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BTJRMP35 · IE00BTJRMP352